Subsea 7 SA (0OGK)
London Exchange · UK · prices in NOK · close of 23 Oct 2026
Key indicators
| Last close | NOK 315.80 |
|---|---|
| 52-week range | 180.50 – 358.40 |
| Return, 1 month / 3 months | −2.0% / −4.2% |
| Return, 1 year / 3 years | +76.0% / +158.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 42 |
| Volatility (1 year) | 30.0% |
| Worst drawdown (1 year) | -13.6% |
| Average daily value traded | 86.57M NOK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Subsea 7 is an offshore engineering, construction and services company based in Oslo, Norway. It works on subsea field development for oil and gas customers, handling project management, engineering, procurement, installation and commissioning of pipelines, risers, umbilicals and related subsea equipment. The company also provides life-of-field services and operates a fleet of specialised vessels that support its offshore work in markets around the world.
Subsea 7 SA trades under the code 0OGK on the London Exchange in UK, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Subsea 7 SA (0OGK) trades on the London Exchange in UK. It last closed at NOK 315.80 on 23 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 279 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 76.0% and over the last three months it fell 4.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 5.8% | ||
| From 52-week high | -9.9% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.2% | ||
| 6-month return | 6.7% | ||
| 12-month return, skipping the last month | 79.7% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.6% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 86.57M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −5.6% |
|---|---|
| 1 month | −2.0% |
| 3 months | −4.2% |
| 6 months | +6.7% |
| 1 year | +76.0% |
| 3 years | +158.0% |
| 5 years | +379.1% |
Signals
| 50-day / 200-day average | 329.41 / 298.39 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 May 2026 | EUR 13.0000 |
| 29 Oct 2025 | EUR 6.5000 |
| 14 May 2025 | EUR 6.5000 |
| 30 Oct 2024 | EUR 3.0000 |
| 3 May 2024 | EUR 3.0000 |
| 20 Apr 2023 | EUR 3.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.